Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis®)

European Journal of Ophthalmology

Volumn 20, Issue 1, 2010, Pages 174-179

  Sharei, Vahid ^a   Höhn, Fabian ^a   Köhler, Thomas ^a   Hattenbach, Lars Olof ^a   Mirshahi, Alireza ^a,b  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Intraocular pressure; Ranibizumab; Wet age related macular degeneration

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUPINE POSITION; TONOMETRY;

EID: 76649136646     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067211002000124     Document Type: Article

References (28)

1. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999; 106: 1056-65.
2. Reche-Frutos J, Calvo-Gonzalez C, Donate-Lopez J, Garcia-Feijoo J, Leila M, Garcia-Sanchez J. Short-term anatomic effect of ranibizumab for polypoidal choroidal vasculopathy. Eur J Ophthalmol 2008; 18: 645-8.
3. Ziemssen F, Heiduschka P, Peters S, Grisanti S, Schraermeyer U. [Chances and risks of anti-VEGF therapy.] Klin Monatsbl Augenheilkd 2008; 225: 770-8.
4. Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents. Am J Ophthalmol 2008; 146: 930-4.
5. Riva CE, Hero M, Titze P, Petrig B. Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graefes Arch Clin Exp Ophthalmol 1997; 235: 618-26.
6. Benz MS, Albini TA, Holz ER, et al. Short-term course of in traocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 2006; 113: 1174-8.
7. Dwinger MC, Pieper-Bodeewes I, Eter N, Holz FG. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection.] Klin Monatsbl Augenheilkd 2005; 222: 638-42.
8. Hollands H, Wong J, Bruen R, Campbell RJ, Sharma S, Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 2007; 42: 807-11.
9. Singh IP, Ahmad SI, Yeh D, et al. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2004; 138: 286-7.
10. Hariprasad SM, Shah GK, Blinder KJ. Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection. Am J Ophthalmol 2006; 141: 200-1.
11. Lee EW, Hariprasad SM, Mieler WF, Newman TL, Apte RS. Short-term intraocular pressure trends after intravitreal triamcinolone injection. Am J Ophthalmol 2007; 143: 365-7.
12. Falkenstein IA, Cheng L, Freeman WR. Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin). Retina 2007; 27: 1044-7.
13. Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 2009; 23: 181-5.
14. Mojica G, Hariprasad SM, Jager RD, Mieler WF. Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration. Br J Ophthalmol 2008; 92: 584.
15. Buchanan RA, Williams TD. Intraocular pressure, ocular pulse pressure, and body position. Am J Optom Physiol Opt 1985; 62: 59-62.
16. Lim KS, Wickremasinghe SS, Cordeiro MF, Bunce C, Khaw PT. Accuracy of intraocular pressure measurements in New Zealand white rabbits. Invest Ophthalmol Vis Sci 2005; 46: 2419-23.
17. Tsukahara S, Sasaki T. Postural change of IOP in normal persons and in patients with primary wide open-angle glaucoma and low-tension glaucoma. Br J Ophthalmol 1984; 68: 389-92.
18. van der Jagt LH, Jansonius NM. Three portable tonometers, the TGDc-01, the ICARE and the Tonopen XL, compared with each other and with Goldmann applanation tonometry*. Ophthalmic Physiol Opt 2005; 25: 429-35.
19. Longo A, Geiser MH, Riva CE. Posture changes and subfoveal choroidal blood flow. Invest Ophthalmol Vis Sci 2004; 45: 546-51.
20. He Z, Bui BV, Vingrys AJ. Effect of repeated IOP challenge on rat retinal function. Invest Ophthalmol Vis Sci 2008; 49: 3026-34.
21. He Z, Bui BV, Vingrys AJ. The rate of functional recovery from acute IOP elevation. Invest Ophthalmol Vis Sci 2006; 47: 4872-80.
22. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 623.
23. Bakri SJ, McCannel CA, Edwards AO, Moshfeghi DM. Persistent ocular hypertension following intravitreal ranibizumab. Graefes Arch Clin Exp Ophthalmol 2008; 246: 955-8.
24. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005; 112: 593-8.
25. McDermott JA. Tonometry and tonography. In: Albert & Jakobiec's Principles and Practice of Ophthalmology, 3rd ed. Philadelphia: Saunders; 2008: 2491-5.
26. Bengtsson B. Comparison of Schiötz and Goldmann tonometry in a population. Acta Ophthalmol (Copenh) 1972; 50: 445-57.
27. Chiara GF, Semes LP, Potter JW, Cutter GR, Tucker WR. Portable tonometers: a clinical comparison of applanation and indentation devices. J Am Optom Assoc 1989; 60: 105-10.
28. Wingert TA, Bassi CJ, McAlister WH, Galanis JC. Clinical evaluation of five portable tonometers. J Am Optom Assoc 1995; 66: 670-4.